First Interstate Bank’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

First Interstate Bank’s Portfolio BIS Stock Details BIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-250	Closed	-$77K	–	776
2015 Q3	$77K	Buy	+250	New	+$59K	0.02%	301

Other funds holding BIS

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CAM

Chesapeake Asset Management New York $131M AUM 40.89% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return

First Interstate Bank's BIS Position: Q4 2015 in Review

First Interstate Bank sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q4 2015, closing a stake of 250 shares — an estimated $77K sold.

First Interstate Bank first reported a position in BIS in Q3 2015 and held it in 1 quarter. The position peaked at $77K in Q3 2015. 15 funds tracked by Wall St. Rank hold BIS as of Q4 2015.

First Interstate Bank reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q4 2015 after selling out during the quarter.
First Interstate Bank sold 250 ProShares UltraShort NASDAQ Biotechnology shares in Q4 2015, an estimated $77K.
First Interstate Bank first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q3 2015 and held it in 1 quarter.
First Interstate Bank's ProShares UltraShort NASDAQ Biotechnology position peaked at $77K in Q3 2015.
15 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q4 2015.

Based on First Interstate Bank's 13F filing for Q4 2015, filed 2 Feb 2016.